|
1.
|
Walsh KE, Mazor KM, Roblin D, Biggins C, Wagner JL, Houlahan K, Li JW, Keuker C, Wasilewski-Masker K, Donovan J, Kanaan A, Weingart SN. Multisite parent-centered risk assessment to reduce pediatric oral chemotherapy errors. J Oncol Pract. 2013 Jan; 9(1):e1-7.
|
|
|
|
|
2.
|
Tjia J, Field TS, Mazor KM, Donovan JL, Kanaan AO, Reed G, Doherty P, Harrold LR, Gurwitz JH. Dementia and risk of adverse warfarin-related events in the nursing home setting. Am J Geriatr Pharmacother. 2012 Oct; 10(5):323-30.
|
|
|
|
|
3.
|
Carey KM, Comee MR, Donovan JL, Kanaan AO. A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke. Ann Pharmacother. 2012 May; 46(5):688-95.
|
|
|
|
|
4.
|
Kanaan AO, Lepage JE, Djazayeri S, Donovan JL. Evaluating the Role of Compression Stockings in Preventing Post thrombotic Syndrome: A Review of the Literature. Thrombosis. 2012; 2012:694851.
|
|
|
|
|
5.
|
Vakil NH, Kanaan AO, Donovan JL. Heparin-induced thrombocytopenia in the pediatric population: a review of current literature. J Pediatr Pharmacol Ther. 2012 Jan; 17(1):12-30.
|
|
|
|
|
6.
|
Miranda AC, Donovan JL, Tran MT, Gore JM. A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux. J Thromb Thrombolysis. 2012 Jan; 33(1):133-5.
|
|
|
|
|
7.
|
Field TS, Garber L, Gagne SJ, Tjia J, Preusse P, Donovan JL, Kanaan AO, Gurwitz JH. Technological resources and personnel costs required to implement an automated alert system for ambulatory physicians when patients are discharged from hospitals to home. Inform Prim Care. 2012; 20(2):87-93.
|
|
|
|
|
8.
|
Subramanian S, Hoover S, Wagner JL, Donovan JL, Kanaan AO, Rochon PA, Gurwitz JH, Field TS. Immediate financial impact of computerized clinical decision support for long-term care residents with renal insufficiency: a case study. J Am Med Inform Assoc. 2012 May 1; 19(3):439-42.
|
|
|
|
|
9.
|
Field TS, Tjia J, Mazor KM, Donovan JL, Kanaan AO, Harrold LR, Reed G, Doherty P, Spenard A, Gurwitz JH. Randomized Trial of a Warfarin Communication Protocol for Nursing Homes: an SBAR-based Approach. Am J Med. 2011 Feb; 124(2):179.e1-7.
|
|
|
|
|
10.
|
Shaw PB, Donovan JL, Tran MT, Lemon SC, Burgwinkle P, Gore J. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic. J Thromb Thrombolysis. 2010 Aug; 30(2):220-5.
|
|
|
|
|
11.
|
Tjia J, Field TS, Garber LD, Donovan JL, Kanaan AO, Raebel MA, Zhao Y, Fuller JC, Gagne SJ, Fischer SH, Gurwitz JH. Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting. Am J Manag Care. 2010 Jul; 16(7):489-96.
|
|
|
|
|
12.
|
Donovan JL, Kanaan AO, Thomson MS, Rochon P, Lee M, Gavendo L, Zhao Y, Baril JL, Field TS, Gurwitz JH. Effect of clinical decision support on psychotropic medication prescribing in the long-term care setting. J Am Geriatr Soc. 2010 May; 58(5):1005-7.
|
|
|
|
|
13.
|
Donovan JL, Tran MT, Kanaan AO. An overview of heparin-induced thrombocytopenia. J Pharm Pract. 2010 Jun; 23(3):226-34.
|
|
|
|
|
14.
|
Herman M, Donovan J, Tran M, McKenna B, Gore JM, Goldberg RJ, Tighe DA. Use of beta-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: are we on target? Am Heart J. 2009 Sep; 158(3):378-85.
|
|
|
|
|
15.
|
Kanaan AO, Donovan JL. Maximizing hospital pharmacy resources with pharmacy students. Ann Pharmacother. 2009 Mar; 43(3):548-9.
|
|
|
|
|
16.
|
Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Clin Ther. 2007 Nov; 29(11):2395-405.
|
|
|
|
|
17.
|
Donovan JL, Schroeder WS, Tran MT, Foster K, Forrest A, Lee TB, Gandhi PJ. Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists. J Manag Care Pharm. 2007 Sep; 13(7):598-606.
|
|
|
|
|
18.
|
Donovan JL, Drake JA, Whittaker P, Tran MT. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance. J Thromb Thrombolysis. 2006 Aug; 22(1):23-30.
|
|
|
|
|
19.
|
Silva MA, Donovan JL, Gandhi PJ, Volturo GA. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? Vasc Health Risk Manag. 2006; 2(1):39-48.
|
|
|
|
